Results 181 to 190 of about 87,478 (258)

Differential regulation of monocyte oxidative burst by isoniazid in healthy and latent tuberculosis-infected subjects. [PDF]

Front Pharmacol
Gal J, Sönnerbrandt M, Braian C, Schön T, Blomgran R.   +4 more
europepmc   +1 more source

Breakthrough Tuberculosis in a Large Cohort of People Living With HIV on Preventive Treatment. [PDF]

Trop Med Int Health
Ruswa N, Günther G, Claassens M.
europepmc   +1 more source

Scaling-up diagnosis and treatment of drug-resistant tuberculosis in Khayelitsha, South Africa [PDF]

, 2011
MSF OCB, MSF South Africa
core   +1 more source

Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial. [PDF]

PLoS Med
Durovni B, Cordeiro-Santos M, Cavalcante SC, Spener-Gomes R, Garcia J, Cohn S, Saraceni V, Kohler B, Moulton LH, Brito da Souza A, Berihun A, Marzinke M, Chaisson RE, Ultra Curto Study Team.   +13 more
europepmc   +1 more source

Cost-effectiveness of latent tuberculosis infection testing and preventive treatment among TB contacts in China: a Markov model. [PDF]

BMC Health Serv Res
Li J, Wen Y, Ge F, Qiu Y, Xu C.
europepmc   +1 more source

Pattern and prevalence of rifampicin and isoniazid-resistant tuberculosis using genotype MTBDR<i>plus</i> assay in Ethiopia. [PDF]

Microbiol Spectr
Getahun M, Ameni G, Mollalign H, Diriba G, Beyene D.   +4 more
europepmc   +1 more source

Common Adverse Reactions and Management Strategies of First-Line Anti-Tuberculosis Drugs. [PDF]

Infect Drug Resist
He K, Zhang J, Du X, He X, Zeng Y, Liu M.   +5 more
europepmc   +1 more source

Evaluation of Xpert MTB/XDR and Deeplex Myc-TB for the Rapid Detection of Drug Resistance in <i>Mycobacterium tuberculosis</i>. [PDF]

Int J Microbiol
Park M, Solanki P, McHugh TD, Kon OM, Satta G.   +4 more
europepmc   +1 more source

National Policy Guidelines for Collaborative TB/HIV Activites [PDF]

, 2008
National AIDS Control Programme, (NACP)
core  

Naturally occurring dinactin targets cpsA protein and kills Mycobacterium tuberculosis by disrupting the proton motive force. [PDF]

Commun Biol
Wang G, Dong W, Bai Y, Li Y, Lu H, Lu W, Wang C, Tang J, Li P, Wang R, Wang X, Chen H, Tan C.   +12 more
europepmc   +1 more source